HYDROQUINONE and SOMNOLENCE

6 reports of this reaction

0.5% of all HYDROQUINONE reports

#100 most reported adverse reaction

Overview

SOMNOLENCE is the #100 most commonly reported adverse reaction for HYDROQUINONE, manufactured by Obagi Cosmeceuticals LLC. There are 6 FDA adverse event reports linking HYDROQUINONE to SOMNOLENCE. This represents approximately 0.5% of all 1,310 adverse event reports for this drug.

Patients taking HYDROQUINONE who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

SOMNOLENCE6 of 1,310 reports

SOMNOLENCE is a less commonly reported adverse event for HYDROQUINONE, but still significant enough to appear in the safety profile.

Other Side Effects of HYDROQUINONE

In addition to somnolence, the following adverse reactions have been reported for HYDROQUINONE:

Frequently Asked Questions

Does HYDROQUINONE cause SOMNOLENCE?

SOMNOLENCE has been reported as an adverse event in 6 FDA reports for HYDROQUINONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is SOMNOLENCE with HYDROQUINONE?

SOMNOLENCE accounts for approximately 0.5% of all adverse event reports for HYDROQUINONE, making it a notable side effect.

What should I do if I experience SOMNOLENCE while taking HYDROQUINONE?

If you experience somnolence while taking HYDROQUINONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.